GERN
USDGeron Corporation Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.200
Kõrge
$1.220
Madal
$1.140
Maht
8.19M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
733.7M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
7.83M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Geron Corporation to Present at Upcoming Investor Conferences
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations
Seotud aktsiad
SKWD
Skyward Specialty Insurance Group Inc.
EBMT
Eagle Bancorp Montana Inc.
TURN
180 Degree Capital Corp.
UPLD
Upland Software Inc.
PFO
Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.